RNhale GmbH is a spin-off originating from the Ludwig-Maximilians-University Munich, aiming to revolutionize the pharmaceutical landscape by developing a unique platform technology for formulating RNA-loaded lipid nanoparticles (LNPs) as an inhalable dry powder. This disruptive approach synergizes technological and pharmaceutical strategies to create a novel therapeutic formulation with significant advantages over common LNP-RNA delivery methods. The target is pulmonary diseases with vast addressable markets and undeniable medical needs.

rnhale

Benjamin Winkeljann

This department provides strategic direction and oversight for the organization.

rnhale

Org chart

Teams

Executive Leadership

Offices

rnhale

Org chart

Teams

Executive Leadership

Offices

Related companies